跳至主要内容
临床试验/NCT04291521
NCT04291521撤回不适用

Prospective Study of Induction Medications Used in the Rapid Sequence Intubation of Trauma Patients and a Comparison of Effects on Outcomes

University of Southern California2 个研究点 分布在 1 个国家目标入组 7,000 人开始时间: 2027年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
撤回
入组人数
7,000
试验地点
2
主要终点
in-hospital mortality

研究概览

简要总结

To compare the outcomes of the use of propofol, etomidate, and ketamine as induction agents for adult trauma patients undergoing intubation within 24 hours of admission. The primary goal is to determine the ideal agent that should be used in this patient population for intubations.

详细描述

Rationale:

Although rapid sequence intubation (RSI) is commonly used in the emergency department (ED) or operating room (OR) for trauma patients, there is not one induction medication which has been deemed the drug of choice for this particular use. There is a wide variation in induction agents used by providers performing RSIs, including propofol, ketamine, methohexital, midazolam, fentanyl, and etomidate. However, no society guidelines exist on the induction agent of choice in trauma for either hemodynamically stable or unstable patients. The purpose of this study is to compare the effects of 3 of the most commonly used induction agents (propofol, etomidate, and ketamine) for RSIs in adult trauma patients on outcomes, such as mortality, and hemodynamic status. Ultimately, the investigators would like to lay the groundwork for developing guidelines that define the ideal induction agent for trauma RSIs.

Intervention: Giving propofol, ketamine, or etomidate as the induction medication for a rapid sequence intubation in trauma patients requiring intubation within 24 hours of admission.

Objectives/Purpose: The purpose of this study is to compare the effects of 3 of the most commonly used induction agents (propofol, etomidate, and ketamine) for RSIs in adult trauma patients on outcomes such as mortality. Additionally, how each agent effects patients' hemodynamic status will be evaluated. Additional outcomes of these medications will be studied in three subsets of patients: 1. those with traumatic brain injuries, 2. elderly patients (>=65-years-old), and 3. those with a low shock index (<0.9) compared to a high shock index (>0.9). Finally, the practices and outcomes of RSIs performed in the ED versus the OR will be compared. Ultimately, the investigators would like to lay the groundwork for developing guidelines that define the ideal induction agent for trauma RSIs.

Study population: Adult trauma patients undergoing RSI within 24 hours of hospital admission

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Trauma patients >=18 yo requiring intubation within 24 hours of admission in either the ED or OR
  • Patients received propofol, etomidate, or ketamine for induction agent

排除标准

  • Patients who were intubated without induction agent medications
  • Patients intubated outside of the hospital or in the field
  • Patients who were intubated with an induction agent other than etomidate, ketamine, or propofol

研究组 & 干预措施

Adult trauma patients requiring RSI

Patients who received an induction medication for intubation.

干预措施: Ketamine (Drug)

Adult trauma patients requiring RSI

Patients who received an induction medication for intubation.

干预措施: Propofol (Drug)

Adult trauma patients requiring RSI

Patients who received an induction medication for intubation.

干预措施: Etomidate (Drug)

结局指标

主要结局

in-hospital mortality

时间窗: through study completion, an average of 1 year

mortality

次要结局

  • intensive care unit length of stay(through study completion, an average of 1 year)
  • mechanical ventilator days(through study completion, an average of 1 year)
  • total hospital length of stay(through study completion, an average of 1 year)
  • Number of participants requiring vasopressor use(24 hours post intubation)
  • 28-day mortality(28 days after admission)
  • discharge disposition(through study completion, an average of 1 year)
  • Number of participants with hypotension(24 hours after intubation)
  • number of complications(through study completion, an average of 1 year)
  • Number of participants with hypotension(30 minutes after intubation)
  • Number of participants requiring vasopressor use(30 minutes after intubation)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Catherine Kuza, MD

Assistant Professor

University of Southern California

研究点 (2)

Loading locations...

相似试验